{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:35:41Z","timestamp":1793140541850,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00436-025-08498-w","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T05:15:45Z","timestamp":1747804545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of neurobiological and immune serum biomarkers with Toxoplasma gondii infection in patients with schizophrenia"],"prefix":"10.1007","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8793-1833","authenticated-orcid":false,"given":"Olga","family":"Abramova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Zorkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Goncharov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia","family":"Abbazova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Baranets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Berdalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriya","family":"Ushakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Zakurazhnaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Morozova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Ochneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Pavlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Andreyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgy","family":"Kostyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Morozova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"issue":"9","key":"8498_CR1","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3923\/pjbs.2020.1131.1137","volume":"23","author":"M Abdel-Latif","year":"2020","unstructured":"Abdel-Latif M, Shaapan M, Salah H, Abu-Sarea EY (2020) Toxoplasmosis in schizophrenic patients: immune-diagnosis and serum dopamine level. Pak J Biol Sci: PJBS 23(9):1131\u20131137. https:\/\/doi.org\/10.3923\/pjbs.2020.1131.1137","journal-title":"Pak J Biol Sci: PJBS"},{"key":"8498_CR2","doi-asserted-by":"publisher","first-page":"107263","DOI":"10.1016\/j.actatropica.2024.107263","volume":"256","author":"AM Ammar","year":"2024","unstructured":"Ammar AM, Nabi SA, El-Ghani HMA (2024) Correlation between toxoplasmosis and schizophrenia in Egyptian patients and its impact on dopamine serum levels. Acta Trop. 256:107263. https:\/\/doi.org\/10.1016\/j.actatropica.2024.107263","journal-title":"Acta Trop."},{"key":"8498_CR3","doi-asserted-by":"publisher","first-page":"1286135","DOI":"10.3389\/fpsyt.2024.1286135","volume":"15","author":"E Beaumont","year":"2024","unstructured":"Beaumont E, Brodeur J, Thomas F, Dujon AM, Lupien SJ, Consortium Signature (2024) Toxoplasma gondii infection in people with schizophrenia is related to higher hair glucocorticoid levels. Front Psychiatry. 15:1286135. https:\/\/doi.org\/10.3389\/fpsyt.2024.1286135","journal-title":"Front Psychiatry."},{"key":"8498_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fnmol.2016.00016","volume":"9","author":"N Bedrossian","year":"2016","unstructured":"Bedrossian N, Haidar M, Fares J, Kobeissy FH, Fares Y (2016) Inflammation and elevation of interleukin-12p40 in patients with schizophrenia. Front Mol Neurosci. 9:16. https:\/\/doi.org\/10.3389\/fnmol.2016.00016. (Published 2016 Mar 22)","journal-title":"Front Mol Neurosci."},{"issue":"3","key":"8498_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/schbul\/sbt006","volume":"39","author":"R Bhadra","year":"2013","unstructured":"Bhadra R, Cobb DA, Weiss LM, Khan IA (2013) Psychiatric disorders in toxoplasma seropositive patients\u2013the CD8 connection. Schizophr Bull 39(3):485\u2013489. https:\/\/doi.org\/10.1093\/schbul\/sbt006","journal-title":"Schizophr Bull"},{"issue":"2","key":"8498_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.celrep.2019.12.019","volume":"30","author":"M Boillat","year":"2020","unstructured":"Boillat M, Hammoudi PM, Dogga SK, Pages S, Goubran M, Rodriguez I, Soldati-Favre D (2020) Neuroinflammation-associated aspecific manipulation of mouse predator fear by Toxoplasma gondii. Cell reports 30(2):320-334.e6. https:\/\/doi.org\/10.1016\/j.celrep.2019.12.019","journal-title":"Cell reports"},{"key":"8498_CR7","doi-asserted-by":"publisher","first-page":"894573","DOI":"10.3389\/fped.2022.894573","volume":"10","author":"L Bollani","year":"2022","unstructured":"Bollani L, Auriti C, Achille C, Garofoli F, De Rose DU, Meroni V, Salvatori G, Tzialla C (2022) Congenital toxoplasmosis: the state of the art. Front Pediatr. 10:894573. https:\/\/doi.org\/10.3389\/fped.2022.894573","journal-title":"Front Pediatr."},{"key":"8498_CR8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jad.2024.01.012","volume":"349","author":"CM Bonn\u00edn","year":"2024","unstructured":"Bonn\u00edn CM, S\u00e1nchez-Moreno J, Lima F et al (2024) Factors associated with the discrepancy between objective and subjective cognitive impairment in bipolar disorder. J Affect Disord 349:210\u2013216. https:\/\/doi.org\/10.1016\/j.jad.2024.01.012","journal-title":"J Affect Disord"},{"issue":"4","key":"8498_CR9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1750-3639.2004.tb00087.x","volume":"14","author":"DA Butterfield","year":"2004","unstructured":"Butterfield DA, Boyd-Kimball D (2004) Amyloid beta-peptide(1\u201342) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain. Brain Pathol. 14(4):426\u201332. https:\/\/doi.org\/10.1111\/j.1750-3639.2004.tb00087.x","journal-title":"Brain Pathol."},{"issue":"2","key":"8498_CR10","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41380-021-01339-z","volume":"27","author":"A Campeau","year":"2022","unstructured":"Campeau A, Mills RH, Stevens T et al (2022) Multi-omics of human plasma reveals molecular features of dysregulated inflammation and accelerated aging in schizophrenia. Mol Psychiatry 27(2):1217\u20131225. https:\/\/doi.org\/10.1038\/s41380-021-01339-z","journal-title":"Mol Psychiatry"},{"issue":"3","key":"8498_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/pathogens9030234","volume":"9","author":"A Cerutti","year":"2020","unstructured":"Cerutti A, Blanchard N, Besteiro S (2020) The bradyzoite: a key developmental stage for the persistence and pathogenesis of toxoplasmosis. Pathogens. 9(3):234. https:\/\/doi.org\/10.3390\/pathogens9030234","journal-title":"Pathogens."},{"issue":"2","key":"8498_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4103\/tp.TP_28_19","volume":"9","author":"A Chaudhury","year":"2019","unstructured":"Chaudhury A, Ramana BV (2019) Schizophrenia and bipolar disorders: the toxoplasma connection. Trop Parasitol. 9(2):71\u201376. https:\/\/doi.org\/10.4103\/tp.TP_28_19","journal-title":"Trop Parasitol."},{"issue":"2","key":"8498_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1176\/appi.prcp.20210041","volume":"4","author":"DG Contopoulos-Ioannidis","year":"2022","unstructured":"Contopoulos-Ioannidis DG, Gianniki M, Ai-Nhi Truong A, Montoya JG (2022) Toxoplasmosis and schizophrenia: a systematic review and meta-analysis of prevalence and associations and future directions. Psychiatr Res Clin Pract. 4(2):48\u201360. https:\/\/doi.org\/10.1176\/appi.prcp.20210041. (Published 2022 Apr 22)","journal-title":"Psychiatr Res Clin Pract."},{"issue":"3","key":"8498_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4306\/pi.2017.14.3.344","volume":"14","author":"\u00d6F Demirel","year":"2017","unstructured":"Demirel \u00d6F, Cetin \u0130, Turan \u015e, Sa\u011flam T, Y\u0131ld\u0131z N, Duran A (2017) Decreased expression of \u03b1-Synuclein, Nogo-A and UCH-L1 in patients with schizophrenia: a preliminary serum study. Psychiatry Investig 14(3):344\u2013349. https:\/\/doi.org\/10.4306\/pi.2017.14.3.344","journal-title":"Psychiatry Investig"},{"issue":"8","key":"8498_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/NMD.0000000000000166","volume":"202","author":"F Dickerson","year":"2014","unstructured":"Dickerson F, Stallings C, Origoni A, Katsafanas E, Schweinfurth L, Savage C, Khushalani S, Yolken R (2014) Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls. J Nerv Ment Dis. 202(8):589\u201393. https:\/\/doi.org\/10.1097\/NMD.0000000000000166","journal-title":"J Nerv Ment Dis."},{"issue":"3","key":"8498_CR16","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.3390\/ijms24032215","volume":"24","author":"EA Ermakov","year":"2023","unstructured":"Ermakov EA, Mednova IA, Boiko AS, Buneva VN, Ivanova SA (2023) Chemokine dysregulation and neuroinflammation in schizophrenia: a systematic review. Int J Mol Sci. 24(3):2215. https:\/\/doi.org\/10.3390\/ijms24032215","journal-title":"Int J Mol Sci."},{"issue":"1","key":"8498_CR17","first-page":"20","volume":"35","author":"J Flegr","year":"2014","unstructured":"Flegr J, Pr\u00edplatova L, Hampl R, Bicikov\u00ed\u00e1 M, Ripova D, Mohr P (2014) Difference of neuro- and immunomodulatory steroids and selected hormone and lipid concentrations between toxoplasma-free and toxoplasma-infected but not CMV-free and CMV-infected schizophrenia patients. Neuro Endocrinol Lett 35(1):20\u201327","journal-title":"Neuro Endocrinol Lett"},{"issue":"3","key":"8498_CR18","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1529-8027.2012.00419.x","volume":"17","author":"N Garcia","year":"2012","unstructured":"Garcia N, Santaf\u00e9 MM, Tom\u00e0s M, Priego M, Obis T, Lanuza MA, Besalduch N, Tom\u00e0s J (2012) Exogenous ciliary neurotrophic factor (CNTF) reduces synaptic depression during repetitive stimulation. J Peripher Nerv Syst. 17(3):312\u201323. https:\/\/doi.org\/10.1111\/j.1529-8027.2012.00419.x","journal-title":"J Peripher Nerv Syst."},{"key":"8498_CR19","unstructured":"Gubareva EV, Goncharov DB, Domonova \u00c9A et al (2013) Use of immunological and molecular biological methods to diagnose cerebral toxoplasmosis in HIV infection. \u2013 Med. Parazitol. (Mosk.). No. 1. S. 7\u201312. \u2013 in Russian"},{"key":"8498_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/B978-0-444-53490-3.00008-X","volume":"114","author":"SK Halonen","year":"2013","unstructured":"Halonen SK, Weiss LM (2013) Toxoplasmosis. Handb Clin Neurol 114:125\u2013145. https:\/\/doi.org\/10.1016\/B978-0-444-53490-3.00008-X","journal-title":"Handb Clin Neurol"},{"key":"8498_CR21","doi-asserted-by":"publisher","first-page":"1043572","DOI":"10.3389\/fimmu.2022.1043572","volume":"13","author":"Y He","year":"2022","unstructured":"He Y, Xu D, Yan Z, Wu Y, Zhang Y, Tian X, Zhu J, Liu Z, Cheng W, Zheng K, Yang X, Yu Y, Pan W (2022) A metabolite attenuates neuroinflammation, synaptic loss and cognitive deficits induced by chronic infection of Toxoplasma gondii. Front Immunol. 13:1043572. https:\/\/doi.org\/10.3389\/fimmu.2022.1043572","journal-title":"Front Immunol."},{"key":"8498_CR22","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jad.2020.11.066","volume":"281","author":"S Hudgens","year":"2021","unstructured":"Hudgens S, Floden L, Blackowicz M et al (2021) Meaningful change in depression symptoms assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-\u00c5sberg Depression Rating Scale (MADRS) among patients with treatment resistant depression in two, randomized, double-blind, active-controlled trials of esketamine nasal spray combined with a new oral antidepressant. J Affect Disord 281:767\u2013775. https:\/\/doi.org\/10.1016\/j.jad.2020.11.066","journal-title":"J Affect Disord"},{"key":"8498_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1471-244X-14-197","volume":"14","author":"E Jelastopulu","year":"2014","unstructured":"Jelastopulu E, Giourou E, Merekoulias G, Mestousi A, Moratis E, Alexopoulos EC (2014) Correlation between the Personal and Social Performance scale (PSP) and the Positive and Negative Syndrome Scale (PANSS) in a Greek sample of patients with schizophrenia. BMC Psychiatry. 14:197. https:\/\/doi.org\/10.1186\/1471-244X-14-197. (Published 2014 Jul 8)","journal-title":"BMC Psychiatry."},{"issue":"3","key":"8498_CR24","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1017\/S0950268814001253","volume":"143","author":"P Kodym","year":"2015","unstructured":"Kodym P, Mal\u00fd M, Beran O, Jilich D, Rozsypal H, Machala L, Holub M (2015) Incidence, immunological and clinical characteristics of reactivation of latent Toxoplasma gondii infection in HIV-infected patients.\u00a0Epidemiol Infect\u00a0143(3):600\u2013607. https:\/\/doi.org\/10.1017\/S0950268814001253","journal-title":"Epidemiology and infection"},{"issue":"9","key":"8498_CR25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606\u2013613. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x","journal-title":"J Gen Intern Med"},{"issue":"1","key":"8498_CR26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5498\/wjp.v6.i1.102","volume":"6","author":"CY Lai","year":"2016","unstructured":"Lai CY, Scarr E, Udawela M, Everall I, Chen WJ, Dean B (2016) Biomarkers in schizophrenia: a focus on blood based diagnostics and theranostics. World J Psychiatry. 6(1):102\u2013117. https:\/\/doi.org\/10.5498\/wjp.v6.i1.102. (Published 2016 Mar 22)","journal-title":"World J Psychiatry."},{"issue":"1","key":"8498_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jagp.2016.09.009","volume":"25","author":"EE Lee","year":"2017","unstructured":"Lee EE, Hong S, Martin AS, Eyler LT, Jeste DV (2017) Inflammation in schizophrenia: cytokine levels and their relationships to demographic and clinical variables. Am J Geriatr Psychiatry 25(1):50\u201361. https:\/\/doi.org\/10.1016\/j.jagp.2016.09.009","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"8498_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.advms.2013.07.006","volume":"59","author":"M Lesi\u0144ska","year":"2014","unstructured":"Lesi\u0144ska M, Hartleb M, Gutkowski K, Nowakowska-Du\u0142awa E (2014) Procalcitonin and macrophage inflammatory protein-1 beta (MIP-1\u03b2) in serum and peritoneal fluid of patients with decompensated cirrhosis and spontaneous bacterial peritonitis. Adv Med Sci. 59(1):52\u20136. https:\/\/doi.org\/10.1016\/j.advms.2013.07.006","journal-title":"Adv Med Sci."},{"issue":"11\u201312","key":"8498_CR29","first-page":"73","volume":"14","author":"JP Lindenmayer","year":"2017","unstructured":"Lindenmayer JP (2017) Are shorter versions of the positive and negative syndrome scale (PANSS) doable? A critical review. Innov Clin Neurosci 14(11\u201312):73\u201376","journal-title":"Innov Clin Neurosci"},{"issue":"Pt B","key":"8498_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bbr.2015.11.005","volume":"298","author":"ME Mahmoud","year":"2016","unstructured":"Mahmoud ME, Ihara F, Fereig RM, Nishimura M, Nishikawa Y (2016) Induction of depression-related behaviors by reactivation of chronic Toxoplasma gondii infection in mice. Behav Brain Res 298(Pt B):125\u201333. https:\/\/doi.org\/10.1016\/j.bbr.2015.11.005","journal-title":"Behav Brain Res."},{"issue":"9","key":"8498_CR31","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.psyneuen.2013.02.009","volume":"38","author":"M Martino","year":"2013","unstructured":"Martino M, Rocchi G, Escelsior A, Contini P, Colicchio S, de Berardis D, Amore M, Fornaro P, Fornaro M (2013) NGF serum levels variations in major depressed patients receiving duloxetine. Psychoneuroendocrinology. 38(9):1824\u20138. https:\/\/doi.org\/10.1016\/j.psyneuen.2013.02.009","journal-title":"Psychoneuroendocrinology."},{"issue":"1","key":"8498_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41398-021-01679-y","volume":"12","author":"BL Mason","year":"2022","unstructured":"Mason BL, Minhajuddin A, Czysz AH, Jha MK, Gadad BS, Mayes TL, Trivedi MH (2022) Fibroblast growth factor 21 (FGF21) is increased in MDD and interacts with body mass index (BMI) to affect depression trajectory. Transl Psychiatry. 12(1):16. https:\/\/doi.org\/10.1038\/s41398-021-01679-y","journal-title":"Transl Psychiatry."},{"issue":"1","key":"8498_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1242\/jeb.074153","volume":"216","author":"GA McConkey","year":"2013","unstructured":"McConkey GA, Martin HL, Bristow GC, Webster JP (2013) Toxoplasma gondii infection and behaviour\u2013location, location, location? J Exp Biol 216(1):113\u2013119. https:\/\/doi.org\/10.1242\/jeb.074153","journal-title":"J Exp Biol"},{"key":"8498_CR34","doi-asserted-by":"publisher","first-page":"101856","DOI":"10.1016\/j.arr.2023.101856","volume":"86","author":"Z Mi","year":"2023","unstructured":"Mi Z, Graham SH (2023) Role of UCHL1 in the pathogenesis of neurodegenerative diseases and brain injury. Ageing Res Rev. 86:101856. https:\/\/doi.org\/10.1016\/j.arr.2023.101856","journal-title":"Ageing Res Rev."},{"issue":"4","key":"8498_CR35","doi-asserted-by":"publisher","first-page":"e0195687","DOI":"10.1371\/journal.pone.0195687","volume":"13","author":"B Moreno-K\u00fcstner","year":"2018","unstructured":"Moreno-K\u00fcstner B, Mart\u00edn C, Pastor L (2018) Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses. PLoS One. 13(4):e0195687. https:\/\/doi.org\/10.1371\/journal.pone.0195687","journal-title":"PLoS One."},{"key":"8498_CR36","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pnpbp.2012.10.022","volume":"48","author":"KS Na","year":"2014","unstructured":"Na KS, Jung HY, Kim YK (2014) The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 48:277\u2013286. https:\/\/doi.org\/10.1016\/j.pnpbp.2012.10.022","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"8498_CR37","doi-asserted-by":"publisher","first-page":"e0218524","DOI":"10.1371\/journal.pone.0218524","volume":"14","author":"T Nayeri Chegeni","year":"2019","unstructured":"Nayeri Chegeni T et al (2019) Is there any association between Toxoplasma gondii infection and depression? A systematic review and meta-analysis. PloS one 14(6):e0218524. https:\/\/doi.org\/10.1371\/journal.pone.0218524","journal-title":"PloS one"},{"key":"8498_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jpsychires.2015.10.002","volume":"72","author":"O Okusaga","year":"2016","unstructured":"Okusaga O, Duncan E, Langenberg P, Brundin L, Fuchs D, Groer MW, Giegling I, Stearns-Yoder KA, Hartmann AM, Konte B, Friedl M, Brenner LA, Lowry CA, Rujescu D, Postolache TT (2016) Combined Toxoplasma gondii seropositivity and high blood kynurenine\u2013linked with nonfatal suicidal self-directed violence in patients with schizophrenia. J Psychiatr Res. 72:74\u201381. https:\/\/doi.org\/10.1016\/j.jpsychires.2015.10.002","journal-title":"J Psychiatr Res."},{"issue":"6","key":"8498_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3390\/brainsci10060369","volume":"10","author":"G Ortiz-Guerrero","year":"2020","unstructured":"Ortiz-Guerrero G, Gonzalez-Reyes RE, de-la-Torre A, Medina-Rinc\u00f3n G, Nava-Mesa MO (2020) Pathophysiological mechanisms of cognitive impairment and neurodegeneration by Toxoplasma gondii infection. Brain Sci 10(6):369. https:\/\/doi.org\/10.3390\/brainsci10060369","journal-title":"Brain Sci"},{"issue":"8","key":"8498_CR40","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3390\/genes13081482","volume":"13","author":"E Osman","year":"2022","unstructured":"Osman E, Mohammad Zahariluddin AS, Sharip S, Md Idris Z, Tan JK (2022) Metabolomic profiling reveals common metabolic alterations in plasma of patients with toxoplasma infection and schizophrenia. Genes (Basel). 13(8):1482. https:\/\/doi.org\/10.3390\/genes13081482","journal-title":"Genes (Basel)."},{"issue":"4","key":"8498_CR41","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","volume":"50","author":"W Ouyang","year":"2019","unstructured":"Ouyang W, O\u2019Garra A (2019) IL-10 Family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity. 50(4):871\u2013891. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.020","journal-title":"Immunity."},{"issue":"4","key":"8498_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.biopsych.2012.01.003","volume":"72","author":"BD Pearce","year":"2012","unstructured":"Pearce BD, Kruszon-Moran D, Jones JL (2012) The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey. Biol Psychiatry. 72(4):290\u20135. https:\/\/doi.org\/10.1016\/j.biopsych.2012.01.003","journal-title":"Biol Psychiatry."},{"issue":"1","key":"8498_CR43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11126-021-09954-3","volume":"93","author":"OF Pinjari","year":"2022","unstructured":"Pinjari OF, Dasgupta SK, Okusaga OO (2022) Plasma soluble P-selectin, Interleukin-6 and S100B protein in patients with schizophrenia: a pilot study. Psychiatr Q 93(1):335\u2013345. https:\/\/doi.org\/10.1007\/s11126-021-09954-3","journal-title":"Psychiatr Q"},{"issue":"9","key":"8498_CR44","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1177\/0004867415575380","volume":"49","author":"Y Qing","year":"2015","unstructured":"Qing Y, Yang J, Wan C (2015) Increased serum fibroblast growth factor 21 levels in patients with schizophrenia. Aust N Z J Psychiatry. 49(9):849\u201350. https:\/\/doi.org\/10.1177\/0004867415575380","journal-title":"Aust N Z J Psychiatry."},{"key":"8498_CR45","doi-asserted-by":"publisher","first-page":"104894","DOI":"10.1016\/j.neubiorev.2022.104894","volume":"142","author":"MJ Rantala","year":"2022","unstructured":"Rantala MJ, Luoto S, Borr\u00e1z-Le\u00f3n JI (2022) Krams I (2022) Schizophrenia: the new etiological synthesis. Neurosci Biobehav Rev 142:104894. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104894","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"8498_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.17816\/CP3728","volume":"4","author":"AM Reznik","year":"2023","unstructured":"Reznik AM, Syunyakov TS, Mudrak AV et al (2023) Treatment of depression with vortioxetine and second generation antipsychotics during the period of remission formation in schizophrenia (interim data analysis). Consort Psychiatr. 4(1):18\u201336. https:\/\/doi.org\/10.17816\/CP3728. (Published 2023 Mar)","journal-title":"Consort Psychiatr."},{"issue":"1","key":"8498_CR47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.17650\/2712-7672-2020-1-1-22-29","volume":"1","author":"DV Romanov","year":"2020","unstructured":"Romanov DV, Brazhnikov AI, Andreyuk DS, Zakharova NV, Bravve LV, Kovaleva VA, Abbazova EV, Goncharov DB, Titova IV, Domonova EA, Kostyuk GP (2020) Schizophrenia and toxoplasmosis: association with catatonic symptoms. Consort Psychiatr. 1(1):22\u201329. https:\/\/doi.org\/10.17650\/2712-7672-2020-1-1-22-29","journal-title":"Consort Psychiatr."},{"issue":"2","key":"8498_CR48","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/schbul\/sbac135","volume":"49","author":"K Runge","year":"2023","unstructured":"Runge K, Balla A, Fiebich BL et al (2023) Neurodegeneration markers in the cerebrospinal fluid of 100 patients with schizophrenia spectrum disorder. Schizophr Bull 49(2):464\u2013473. https:\/\/doi.org\/10.1093\/schbul\/sbac135","journal-title":"Schizophr Bull"},{"key":"8498_CR49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.comppsych.2018.02.002","volume":"82","author":"M Sagud","year":"2018","unstructured":"Sagud M, Vlatkovic S, Svob Strac D et al (2018) Latent Toxoplasma gondii infection is associated with decreased serum triglyceride to high-density lipoprotein cholesterol ratio in male patients with schizophrenia. Compr Psychiatry 82:115\u2013120. https:\/\/doi.org\/10.1016\/j.comppsych.2018.02.002","journal-title":"Compr Psychiatry"},{"issue":"1","key":"8498_CR50","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1080\/21505594.2021.2012346","volume":"12","author":"SG Sanchez","year":"2021","unstructured":"Sanchez SG, Besteiro S (2021) The pathogenicity and virulence of Toxoplasma gondii. Virulence 12(1):3095\u20133114. https:\/\/doi.org\/10.1080\/21505594.2021.2012346","journal-title":"Virulence"},{"issue":"9","key":"8498_CR51","doi-asserted-by":"publisher","first-page":"e0184930","DOI":"10.1371\/journal.pone.0184930","volume":"12","author":"EV Stepanova","year":"2017","unstructured":"Stepanova EV, Kondrashin AV, Sergiev VP, Morozova LF, Turbabina NA, Maksimova MS, Brazhnikov AI, Shevchenko SB, Morozov EN (2017) Significance of chronic toxoplasmosis in epidemiology of road traffic accidents in Russian Federation. PLoS One. 12(9):e0184930. https:\/\/doi.org\/10.1371\/journal.pone.0184930","journal-title":"PLoS One."},{"issue":"7","key":"8498_CR52","doi-asserted-by":"publisher","first-page":"e0219454","DOI":"10.1371\/journal.pone.0219454","volume":"14","author":"EV Stepanova","year":"2019","unstructured":"Stepanova EV, Kondrashin AV, Sergiev VP, Morozova LF, Turbabina NA, Maksimova MS, Romanov DV, Kinkulkina MA, Lazareva AV, Morozov EN (2019) Toxoplasmosis and mental disorders in the Russian Federation (with special reference to schizophrenia). PLoS One. 14(7):e0219454. https:\/\/doi.org\/10.1371\/journal.pone.0219454","journal-title":"PLoS One."},{"key":"8498_CR53","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.schres.2022.03.004","volume":"243","author":"WS Stone","year":"2022","unstructured":"Stone WS, Phillips MR, Yang LH, Kegeles LS, Susser ES, Lieberman JA (2022) Neurodegenerative model of schizophrenia: growing evidence to support a revisit. Schizophr Res 243:154\u2013162. https:\/\/doi.org\/10.1016\/j.schres.2022.03.004","journal-title":"Schizophr Res"},{"issue":"4","key":"8498_CR54","doi-asserted-by":"publisher","first-page":"183","DOI":"10.7224\/1537-2073.2015-028","volume":"18","author":"LB Strober","year":"2016","unstructured":"Strober LB, Binder A, Nikelshpur OM, Chiaravalloti N, DeLuca J (2016) The perceived deficits questionnaire: perception, deficit, or distress? Int J MS Care 18(4):183\u2013190. https:\/\/doi.org\/10.7224\/1537-2073.2015-028","journal-title":"Int J MS Care"},{"issue":"3","key":"8498_CR55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/acps.12423","volume":"132","author":"AL Sutterland","year":"2015","unstructured":"Sutterland AL, Fond G, Kuin A, Koeter MW, Lutter R, van Gool T, Yolken R, Szoke A, Leboyer M, de Haan L (2015) Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. Acta Psychiatr Scand. 132(3):161\u201379. https:\/\/doi.org\/10.1111\/acps.12423","journal-title":"Acta Psychiatr Scand."},{"issue":"9","key":"8498_CR56","doi-asserted-by":"publisher","first-page":"e00505","DOI":"10.1128\/JCM.00505-20","volume":"58","author":"A Teimouri","year":"2020","unstructured":"Teimouri A et al (2020) Role of Toxoplasma gondii IgG avidity testing in discriminating between acute and chronic toxoplasmosis in pregnancy. J Clin Microbiol 58(9):e00505-20. https:\/\/doi.org\/10.1128\/JCM.00505-20","journal-title":"J Clin Microbiol"},{"issue":"3","key":"8498_CR57","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/schbul\/sbl050","volume":"33","author":"EF Torrey","year":"2007","unstructured":"Torrey EF, Bartko JJ, Lun ZR, Yolken RH (2007) Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull. 33(3):729\u201336. https:\/\/doi.org\/10.1093\/schbul\/sbl050","journal-title":"Schizophr Bull."},{"issue":"8","key":"8498_CR58","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/mp.2016.90","volume":"21","author":"MO Tr\u00e9panier","year":"2016","unstructured":"Tr\u00e9panier MO, Hopperton KE, Mizrahi R, Mechawar N, Bazinet RP (2016) Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. Mol Psychiatry 21(8):1009\u20131026. https:\/\/doi.org\/10.1038\/mp.2016.90","journal-title":"Mol Psychiatry"},{"issue":"23","key":"8498_CR59","doi-asserted-by":"publisher","first-page":"14574","DOI":"10.3390\/ijms232314574","volume":"23","author":"A Viloti\u0107","year":"2022","unstructured":"Viloti\u0107 A, Nacka-Aleksi\u0107 M, Pirkovi\u0107 A, Boji\u0107-Trbojevi\u0107 \u017d, Dekanski D, Jovanovi\u0107 Krivoku\u0107a M (2022) IL-6 and IL-8: an overview of their roles in healthy and pathological pregnancies. Int J Mol Sci. 23(23):14574. https:\/\/doi.org\/10.3390\/ijms232314574","journal-title":"Int J Mol Sci."},{"key":"8498_CR60","doi-asserted-by":"publisher","first-page":"797386","DOI":"10.3389\/fpsyt.2021.797386","volume":"12","author":"P W\u00f3jciak","year":"2021","unstructured":"W\u00f3jciak P, Domowicz K, Zab\u0142ocka M, Michalak M, Rybakowski JK (2021) Association of negative symptoms of schizophrenia assessed by the BNSS and SNS scales with neuropsychological performance: a gender effect. Front Psychiatry. 12:797386. https:\/\/doi.org\/10.3389\/fpsyt.2021.797386. (Published 2021 Dec 24)","journal-title":"Front Psychiatry."},{"key":"8498_CR61","doi-asserted-by":"publisher","first-page":"584743","DOI":"10.3389\/fnagi.2020.584743","volume":"12","author":"Y Xiang","year":"2020","unstructured":"Xiang Y, Xin J, Le W, Yang Y (2020) Neurogranin: a potential biomarker of neurological and mental diseases. Front Aging Neurosci. 12:584743. https:\/\/doi.org\/10.3389\/fnagi.2020.584743","journal-title":"Front Aging Neurosci."},{"key":"8498_CR62","doi-asserted-by":"publisher","first-page":"104587","DOI":"10.1016\/j.micpath.2020.104587","volume":"149","author":"F Xu","year":"2020","unstructured":"Xu F, Ma X, Zhu Y, Sutterland A, Cheng R, Miao S, Chen J, Qiu L, Zhou Y (2020) Effects of Toxoplasma gondii infection and schizophrenia comorbidity on serum lipid profile: a population retrospective study from Eastern China. Microb Pathog. 149:104587. https:\/\/doi.org\/10.1016\/j.micpath.2020.104587","journal-title":"Microb Pathog."},{"issue":"3","key":"8498_CR63","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/glia.24100","volume":"70","author":"H Yoon","year":"2022","unstructured":"Yoon H, Triplet EM, Simon WL, Choi CI, Kleppe LS, De Vita E, Miller AK, Scarisbrick IA (2022) Blocking Kallikrein 6 promotes developmental myelination. Glia. 70(3):430\u2013450. https:\/\/doi.org\/10.1002\/glia.24100","journal-title":"Glia."},{"issue":"4","key":"8498_CR64","doi-asserted-by":"publisher","first-page":"474","DOI":"10.62641\/aep.v52i4.1667","volume":"52","author":"B Zhou","year":"2024","unstructured":"Zhou B, Mu K, Yu X, Shi X (2024) Serum levels and clinical significance of NSE, BDNF and CNTF in patients with cancer-associated ischemic stroke complicated with post-stroke depression. Actas Esp Psiquiatr. 52(4):474\u2013483. https:\/\/doi.org\/10.62641\/aep.v52i4.1667","journal-title":"Actas Esp Psiquiatr."}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-025-08498-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-025-08498-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-025-08498-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T15:06:34Z","timestamp":1748963194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-025-08498-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["8498"],"URL":"https:\/\/doi.org\/10.1007\/s00436-025-08498-w","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the guidelines of the Declaration of Helsinki. The procedures involving experiments on human subjects were performed in accordance with the ethical standards (Protocol No. 2\/28.10.2020 of the Local Ethic Committee of Mental Health Clinic No. 1,named after N.A. Alexeev of the Department of Health of Moscow).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}